Novartis to acquire Avidity Biosciences for about $12B

Novartis has been proactively striking deals this year to address the impending patent cliff for some of its blockbuster drugs, including Entresto for heart failure, Xolair for asthma and Cosentyx for autoimmune diseases.

  Business   Oct 27, 2025   0   25  Add to Reading List
Novartis to acquire Avidity Biosciences for about $12B
Why the Hen Does Not Have Teeth Story Book

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

It’s an amazing story, composed out of imagination and rich with lessons. You’ll learn how to be morally upright, avoid immoral things, and understand how words can make or destroy peace and harmony.

Click the image to get your copy!

Why the Hen Does Not Have Teeth Story Book

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

It’s an amazing story, composed out of imagination and rich with lessons. You’ll learn how to be morally upright, avoid immoral things, and understand how words can make or destroy peace and harmony.

Click the image to get your copy!

Why the Hen Does Not Have Teeth Story Book

WHY THE HEN DOES NOT HAVE TEETH STORY BOOK

It’s an amazing story, composed out of imagination and rich with lessons. You’ll learn how to be morally upright, avoid immoral things, and understand how words can make or destroy peace and harmony.

Click the image to get your copy!

Novartis has been proactively striking deals this year to address the impending patent cliff for some of its blockbuster drugs, including Entresto for heart failure, Xolair for asthma and Cosentyx for autoimmune diseases.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow